King Bio Recalls Dr. King's SafeCare Rx Procrastination Due to Microbial Contamination
King Bio Inc. is recalling 95 bottles of Dr. King's SafeCare Rx Procrastination because the product contains microbial contamination.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Microbial contamination"
Plain-English summary
King Bio Inc., located in Asheville, NC, has initiated a recall of Dr. King's SafeCare Rx Procrastination, a 2 fl. oz. (59 mL) homeopathic remedy. The company is recalling 95 bottles due to microbial contamination found in the product.
The affected lots are 091715C with an expiration date of September 2018 and 091316C with an expiration date of September 2019. These products were distributed nationwide in the United States, as well as in Canada and Australia.
Consumers who possess this product are advised to stop using it immediately and contact King Bio Inc. for further instructions or a refund.
The recalled product
- Product
- Dr. King's SafeCare Rx Procrastination, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955276029, NDC 57955-2761-2
- Manufacturer
- King Bio Inc.
- Category
- Drug — Homeopathic Remedy
- Hazard
- Affected units
- 95
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 091715C Exp. 09/18
- 091316C Exp. 09/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- SevereSentara Recalls Ascorbic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-02-03
- SevereSafecor Health Recalls Doxycycline Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2017-06-21
- SevereRed Mountain Compounding Recalls S-Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- HighHealth Innovations Pharmacy Recalls Hydroxyurea Suspension Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- ModerateSafecor Recalls Acyclovir 400mg Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2017-06-21
- SevereRXQ Compounding Recalls Dextrose 50% Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-08-14